Clinical Trial Update: Safety and Tolerability Evaluationof Phascolarcobacterium Faecium [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability evaluation of Phascolarcobacterium Faecium has completed, reporting initial safety data in early-stage testing for obesity and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Phascolarcobacterium Faecium

Snippet

Sponsor: Spanish National Research Council | Conditions: Health, Obesity Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED